SCHEMBL6502154

SCHEMBL6502154

Clc1ccc([CH]CCN2CCOCC2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.51
▸ KMT2A Q03164 3/20 0.51
▸ MAPT P10636 2/20 0.51
▸ HTR1A P08908 1/20 0.48
▸ MAOA P21397 1/20 0.48
▸ MAOB P27338 1/20 0.48
▸ KCNH2 Q12809 1/20 0.48
▸ CD274 Q9NZQ7 1/20 0.48
▸ SMN1; SMN2 Q16637 3/20 0.46
▸ CNR1 P21554 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ SIGMAR1 Q99720 1/20 0.44
▸ CYP2A13 Q16696 1/20 0.44
▸ KDM4E B2RXH2 2/20 0.44
▸ AGTR1 P30556 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ MAPK1 P28482 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27903062 0.83 ALDH1A1 (0.46) ALDH1A1KMT2AMAPTHTR1AMAOA
SCHEMBL7408919 0.83 SIGMAR1 (0.53) ALDH1A1KMT2AMAPTCNR1NPC1
SCHEMBL11474889 0.76 ALDH1A1 (0.58) ALDH1A1KMT2AMAPTHTR1AMAOA
SCHEMBL11474887 0.76 ALDH1A1 (0.58) ALDH1A1KMT2AMAPTHTR1AMAOA
SCHEMBL8636775 0.74 CNR1 (0.55) ALDH1A1SMN1; SMN2CNR1L3MBTL1SIGMAR1
SCHEMBL11475244 0.74 KMT2A (0.46) ALDH1A1KMT2AMAPTHTR1AMAOA
SCHEMBL24351544 0.74 SIGMAR1 (0.70) ALDH1A1KMT2AMAPTHTR1AMAOA
SCHEMBL11487214 0.73 HRH3 (0.51) ALDH1A1KMT2AMAPTHTR1AMAOA
SCHEMBL780339 0.72 HSP90AA1 (0.74) ALDH1A1KMT2AMAPTHTR1AMAOA
SCHEMBL780338 0.72 HSP90AA1 (0.74) ALDH1A1KMT2AMAPTHTR1AMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6844347-B1 Cyclic guanosine monophosphate modulators; cardiovascular diseases; guanylate cyclase activation AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2005-01-18 — — US disclosed
Send feedback